QuidelOrtho Corporation
$12.89
▲
4.04%
2026-04-21 09:01:00
www.quidelortho.com
NMS: QDEL
Explore QuidelOrtho Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$877.57 M
Current Price
$12.89
52W High / Low
$38.99 / $11.61
Stock P/E
—
Book Value
$28.28
Dividend Yield
—
ROCE
1.14%
ROE
-46.15%
Face Value
—
EPS
$-16.69
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
6,500
Beta
0.92
Debt / Equity
148.6
Current Ratio
1.5
Quick Ratio
0.9
Forward P/E
4.64
Price / Sales
0.35
Enterprise Value
$3.63 B
EV / EBITDA
6.45
EV / Revenue
1.33
Rating
None
Target Price
$34.67
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Profound Medical Corp. | $7.15 | — | $331 M | — | -57.78% | -67.11% | $12.4 / $5.23 | $1.83 |
| 2. | Globus Medical, Inc. | $96.1 | 24.49 | $13.01 B | — | 11.18% | 12.29% | $101.4 / $51.79 | $33.86 |
| 3. | OrthoPediatrics Corp. | $16.65 | — | $420.89 M | — | -6.27% | -11.31% | $23.7 / $14.91 | $13.81 |
| 4. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 5. | Beyond Air, Inc. | $0.55 | — | $6.22 M | — | -177.71% | -2.4% | $5.84 / $0.43 | $0.96 |
| 6. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 7. | Lifeward Ltd. | $7.52 | — | $11.49 M | — | -155.52% | -1.46% | $18.6 / $4.14 | $5.52 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 723.6 M | 699.9 M | 613.9 M | 692.8 M | 707.8 M | — |
| Operating Profit | -37.3 M | 45.2 M | -1.8 M | 48.7 M | 15.2 M | — |
| Net Profit | -130.7 M | -733 M | -255.4 M | -12.7 M | -178.4 M | — |
| EPS in Rs | -1.92 | -10.77 | -3.75 | -0.19 | -2.62 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.73 B | 2.78 B | 3 B | 3.27 B |
| Operating Profit | 54.8 M | 45.8 M | 257 M | 982.5 M |
| Net Profit | -1.13 B | -2.05 B | -10.1 M | 548.7 M |
| EPS in Rs | -16.62 | -30.14 | -0.15 | 8.06 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.77 B | 6.42 B | 8.56 B | 8.86 B |
| Total Liabilities | 3.85 B | 3.44 B | 3.56 B | 3.92 B |
| Equity | 1.92 B | 2.98 B | 5.01 B | 4.93 B |
| Current Assets | 1.45 B | 1.22 B | 1.31 B | 1.58 B |
| Current Liabilities | 966.1 M | 998.8 M | 833.8 M | 1.01 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 105.2 M | 83 M | 280.2 M | 885.3 M |
| Investing CF | -192.7 M | -149.9 M | -187.6 M | -1.64 B |
| Financing CF | 155.8 M | 48.8 M | -265.8 M | 252 M |
| Free CF | -83 M | -112.1 M | 70.9 M | 744.4 M |
| Capex | -188.2 M | -195.1 M | -209.3 M | -140.9 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -7.17% | -8.21% | — | — |
| Earnings Growth % | -20216.83% | -101.84% | — | — |
| Profit Margin % | -73.74% | -0.34% | 16.8% | — |
| Operating Margin % | 1.65% | 8.57% | 30.08% | — |
| Gross Margin % | 46.23% | 49.94% | 59.28% | — |
| EBITDA Margin % | -53.53% | 20.25% | 33.5% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.